Rajiv Dhand is a Respiratory physician affiliated with University of Tennessee Medical Center. OpenAlex indexes 234 publications with 8,612 citations (h-index 47); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1940 Alcoa Hwy
Suite E210
Knoxville, TN 379202244
Telephone
865-524-7471Registry record last updated 30 Jan 2012.
Clinical trials
- COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers
Sponsor: University of Tennessee Graduate School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech USA, Inc.Program year20258 payments
- Viatris Specialty LLCProgram year20259 payments
- GlaxoSmithKline, LLC.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
89.2%Corticosteroid56.6%Symbicort26%Trelegy Ellipta23%Fluticasone Propionate18%Breztri Aerosphere15%Budesonide-Formoterol Fumarate12%Breo Ellipta6%Part D<11 patientsbeta2-Adrenergic Agonist18.6%Albuterol Sulfate Hfa100%Part D≥27 patients+ 3 more classes in this area
Metabolism & gastrointestinal
4.6%Proton pump inhibitor4.6%Omeprazole100%Part D<11 patientsBlood & clotting
3.4%Human alpha-1 Proteinase Inhibitor3.4%Prolastin C100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease
American Journal of Respiratory and Critical Care Medicine
2021 - Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease
Mayo Clinic Proceedings
2021 - Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2
American Journal of Respiratory and Critical Care Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Mitchell Goldman, MD
University of Tennessee Medical Center
Wahid Hanna, MD
University of Tennessee Medical Center
Dale Wortham, MD
University of Tennessee Medical Center
Yasir Akhtar, MD
University of Tennessee Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”